<\/p>\n
Encorate Chrono<\/strong> este un 200 \/ 300 \/ 400 \/ 500 \/ 600 mg sodium valproate \/ valproic acid extended-release (chrono \/ CR) tablet<\/strong> from Sun Pharma — an antiepileptic \/ mood-stabiliser \/ migraine preventive. In migraine prevention it is used at 500-1,500 mg once daily<\/strong> as a third- or fourth-line preventive after propranolol, topiramate, and amitriptyline. Absolute contraindication in pregnancy and in women of childbearing potential without pregnancy-prevention programme<\/strong> — valproate causes a 10% risk of major congenital malformations (neural tube defects, craniofacial, cardiac, limb, urogenital) and a 30-40% risk of neurodevelopmental impairment (reduced IQ 7-10 points, autism spectrum). The EMA and MHRA have issued progressively stricter prescribing restrictions since 2014. Other important side effects: hepatotoxicity (idiosyncratic; serious rarely fatal), pancreatitis, thrombocytopenia, hyperammonaemia, weight gain, hair loss, tremor, and polycystic ovarian syndrome in women.<\/p>\n<\/div>\n Encorate Chrono is an oral extended-release (chrono \/ CR) tablet of sodium valproate \/ valproic acid 200 \/ 300 \/ 400 \/ 500 \/ 600 mg<\/strong> from Sun Pharma, supplied in 30-180 tablet packs. Valproate is a branched short-chain fatty acid originally used as a solvent in pharmaceutical chemistry, later serendipitously discovered to have antiepileptic activity. It has been a first-line anticonvulsant for generalised and partial epilepsy since the 1970s and became the third drug with US FDA approval for migraine prophylaxis in 1996 (after propranolol and timolol).<\/p>\n Numele Chrono \/ CR extended-release formulation<\/strong> allows once-daily dosing with smoother plasma levels than the immediate-release formulation — better tolerability (less peak-related nausea and tremor) and better adherence.<\/p>\n Valproate works through multiple mechanisms relevant to migraine:<\/p>\n In migraine-prevention trials (Jensen 1994, Mathew 1995, Klapper 1997), valproate 500-1,500 mg\/day reduced monthly migraine frequency by ~50% in about half of treated patients.<\/p>\n Valproate is titrated upward<\/strong> over 2-4 weeks to minimise nausea:<\/p>\n Monitorizare:<\/strong><\/p>\n \u00centrerupere:<\/strong> taper over 2-4 weeks if stopping. In patients with co-existing epilepsy, never stop valproate without neurology input (seizure risk).<\/p>\n Foarte frecvent (>10%):<\/strong> nausea, dyspepsia, drowsiness, tremor, weight gain, hair thinning \/ hair loss, alopecia (usually transient; hair regrows after dose reduction or stopping).<\/p>\n Frecvente (1-10%):<\/strong> ataxia, dizziness, headache, transient elevation of LFTs, thrombocytopenia (usually mild and dose-related), amenorrhoea or irregular menses, polycystic ovarian syndrome (in younger women), decreased libido, peripheral oedema.<\/p>\n Pu\u021bin frecvente, dar grave:<\/strong><\/p>\n Al\u0103ptarea:<\/strong> valproate passes into milk in low amounts (milk\/plasma ratio ~0.02). Generally considered acceptable during breastfeeding if the drug is needed; monitor the infant for unusual lethargy or poor feeding.<\/p>\n Store below 25°C in original blister. Protect from moisture. Keep out of reach of children.<\/p>\n Allow 8-12 weeks at target dose for full effect. Keep a migraine diary recording days per month at baseline and at week 12. A clinically meaningful response is a 50% reduction in monthly migraine days.<\/p>\n Nu.<\/strong> Valproate is one of the most teratogenic drugs in clinical use (~10% malformation risk, 30-40% neurodevelopmental impairment risk). Women of childbearing potential should be switched to a safer preventive (propranolol<\/a> is preferred in pregnancy) before conception. A 3-month washout is usually recommended before trying to conceive. Valproate should not be used in women planning or able to become pregnant without a formal pregnancy-prevention programme.<\/p>\n Same molecule (sodium valproate \/ valproic acid), different release profile. Encorate Chrono is extended-release for once-daily dosing with smoother plasma levels. Better tolerability, better adherence. Encorate IR<\/a> requires twice-daily dosing.<\/p>\n Yes — weight gain is one of the most common side effects (average 3-5 kg over 6-12 months, more in some). Mechanism includes increased appetite, possibly altered glucose metabolism. If weight gain is problematic, consider switching to topiramate<\/a> (which causes weight loss) or propranolol<\/a> (weight-neutral).<\/p>\n Valproate can cause hepatotoxicity, pancreatitis, thrombocytopenia, and hyperammonaemia. Baseline + periodic LFTs, full blood count, and clinical monitoring catch problems early. Therapeutic drug monitoring (levels 50-100 μg\/mL) is not routinely needed for migraine prevention — dose by clinical response.<\/p>\n Avoid regular or heavy alcohol use. Alcohol is additive with valproate’s sedation and adds to hepatic stress. Occasional small amounts are not absolutely contraindicated but regular drinking raises the risk of hepatotoxicity. Alcohol is also a common migraine trigger; reducing intake often improves migraine independent of valproate.<\/p>\n No — taper over 2-4 weeks. Abrupt discontinuation can trigger rebound migraine and, in patients with any seizure tendency, seizure.<\/p>\n You can buy Encorate Chrono (sodium valproate 200 \/ 300 \/ 400 \/ 500 \/ 600 mg extended-release (chrono \/ CR) tablet, 30-180 tablet packs) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n \ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n <\/p>\n Alte produse din Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n Encorate Chrono is sodium valproate 200 \/ 300 \/ 400 \/ 500 \/ 600 mg extended-release (chrono \/ CR) tablets from Sun Pharma \u2014 once-daily dosing with smoother plasma levels than immediate-release Encorate. For migraine prevention: start 500 mg nightly, titrate to 1,000 mg nightly (range 500-1,500 mg). Same pregnancy and monitoring restrictions as all valproate products.<\/p>","protected":false},"featured_media":61071,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3553,3141,3223,3342,3554],"product_tag":[4973,4677,4898],"class_list":{"0":"post-61070","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-migraine","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_cat-general-health","10":"product_cat-migraine-treatment","11":"product_tag-encorate-chrono","12":"product_tag-sodium-valproate","13":"product_tag-valproic-acid","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/61070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=61070"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/61071"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=61070"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=61070"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=61070"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=61070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Is Encorate Chrono?<\/h2>\n
How Valproate Prevents Migraine<\/h2>\n
\n
Utiliz\u0103ri aprobate<\/h2>\n
\n
Encorate Chrono Dosage for Migraine Prevention<\/h2>\n
\n
\n
Efecte Secundare<\/h2>\n
\n
Contraindica\u021bii<\/h2>\n
\n
Interac\u021biuni medicamentoase<\/h2>\n
\n
Depozitare<\/h2>\n
\u00centreb\u0103ri frecvente<\/h2>\n
How long until Encorate Chrono starts preventing migraines?<\/h3>\n
Is Encorate Chrono safe if I am planning pregnancy?<\/h3>\n
Why is the extended-release form different from Encorate IR?<\/h3>\n
Will Encorate Chrono make me gain weight?<\/h3>\n
Why do I need blood tests on Encorate Chrono?<\/h3>\n
Can I drink alcohol on Encorate Chrono?<\/h3>\n
Can I stop Encorate Chrono abruptly?<\/h3>\n
Where can I buy Encorate Chrono online?<\/h3>\n
Tratamente pentru Migren\u0103 Asem\u0103n\u0103toare pe MedsBase<\/h2>\n
\n
De ce s\u0103 comanzi de la MedsBase<\/h3>\n
Alternative conexe<\/h3>\n
\n